PROGNOSIS BIOMARKERS IN CARTILAGE DISORDERS

This application is directed to the use of biomarkers for prognosing disease severity in a subject having a cartilage disorder, such as osteoarthritis, cartilage injury, fractures affecting joint cartilage or surgical procedures with impact on joint cartilage (e.g. Microfracture). It also describes...

Full description

Saved in:
Bibliographic Details
Main Authors BERTON, ALIX, ANNE, SIMONE, FARMER, PIERRE, JACQUES, LADEL, CHRISTOPH, HUBERTUS, VALSESIA, ARMAND
Format Patent
LanguageEnglish
French
Published 13.02.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This application is directed to the use of biomarkers for prognosing disease severity in a subject having a cartilage disorder, such as osteoarthritis, cartilage injury, fractures affecting joint cartilage or surgical procedures with impact on joint cartilage (e.g. Microfracture). It also describes method of predicting sensitivity to a drug prior to drug administration in a subject having a cartilage disorder, as well as clinical management based on the likelihood of said patients of being non- sensitive, sensitive or highly sensitive to a drug treatment. Cette invention concerne l'utilisation de biomarqueurs pour le pronostic de la sévérité d'une maladie chez un sujet présentant un trouble du cartilage, tel que l'arthrose, une lésion cartilagineuse, des fractures affectant le cartilage de l'articulation ou des interventions chirurgicales ayant un impact sur le cartilage de l'articulation (par exemple une microfracture). L'invention concerne également un procédé de prédiction de la sensibilité vis-à-vis d'un médicament avant l'administration du médicament chez un sujet présentant un trouble du cartilage, ainsi qu'une gestion clinique sur la base de la susceptibilité desdits patients d'être insensibles, sensibles ou hautement sensibles à un traitement par un médicament.
Bibliography:Application Number: WO2013EP66422